Anti-PAI1 Antibody (8G921) is a Rabbit antibody targeting PAI1. Anti-PAI1 Antibody (8G921) can be used in FCM, WB.

IgG

8G921

Human

1. 25 ug total protein per lane of various lysates (see on figure) probed with PAI1 monoclonal antibody, unconjugated (TMAB-09935) at 1: 1000 dilution and 4°C overnight incubation. Followed by conjugated secondary antibody incubation at r. T. for 60 min.
2. The HUVEC (H) cells were fixed with 4% PFA (10 min at r. T.) and then permeabilized with 90% ice-cold methanol for 20 min at -20℃, the cells then were incubated in 5% BSA to block non-specific protein-protein interactions (30 min at r. T.), followed by secondary antibody incubation for 40 min at room temperature. Primary Antibody (green): Rabbit Anti-PAI1 antibody (TMAB-09935, 1: 100); Isotype Control (orange): Rabbit IgG. Blank control (black): PBS. Acquisition of 20,000 events was performed.

FCM=1:50-100; WB=1:500-2000

Monoclonal

A synthesized peptide: human PAI 1

Human

SERPINE1

Plasminogen activator inhibitor 1

Serine protease inhibitor. This inhibitor acts as 'bait' for tissue plasminogen activator, urokinase, protein C and matriptase-3/TMPRSS7. Its rapid interaction with PLAT may function as a major control point in the regulation of fibrinolysis.